Wright Private Asset Management’s Pfizer PFE Stock Holding History

Wright Private Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$655K	Buy	+24,653	New	+$681K	5.99%	2

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wright Private Asset Management's PFE Position: Q2 2013 in Review

Wright Private Asset Management opened a new position in Pfizer (PFE) in Q2 2013: 24,653 shares worth $655K. The stake represents 5.99% of the portfolio and ranks #2 among its holdings.

1,627 funds tracked by Wall St. Rank hold PFE as of Q2 2013.

Wright Private Asset Management held 24,653 shares of Pfizer worth $655K as of Q2 2013.
Pfizer was a new Wright Private Asset Management position in Q2 2013.
Pfizer made up 5.99% of Wright Private Asset Management's portfolio in Q2 2013, its #2 holding.
1,627 funds tracked by Wall St. Rank held Pfizer as of Q2 2013.

Based on Wright Private Asset Management's 13F filing for Q2 2013, filed 31 Jul 2013.